KEGG   DRUG: Suptavumab
Entry
D10991                      Drug                                   
Name
Suptavumab (USAN/INN)
Sequence
(Heavy chain)
EVQLVESGGD LVQPGRSLRL SCVASGFTFD DYAMHWVRQA PGKGLEWVSG VSWSGSTVGY
ADSVKGRFTV SRDNAQKSLY LQMNSLRAED TALYYCVKDA YKFNYYYYGL DVWGQGTTVT
VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL
QSSGLYSLSS VVTVPSSSLG TQTYICNVNH KPSNTKVDKK VEPKSCDKTH TCPPCPAPEL
LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE
QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS
RDELTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK
SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PG
(Light chain)
EIVMTQSPAT LSVSPGERAT LSCRASQTIL SNLAWYLQKP GQAPRLLIYG ASTRATGLPA
RFSGSGSGTE FTLTISSLQS EDFAVYYCQQ YNNWPLTFGG GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H150-H206, H226-L214, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'96, H'150^H'206, H'226-L'214, H'267-H'327, H'373-H'431, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  Type
Peptide
Efficacy
Antiviral
  Type
Monoclonal antibody
Comment
Prevention of medically attended lower raspiratory tract disease due to respiratory syncytial virus
Target
RSV F protein [KO:K19261]
Brite
Antimicrobials [BR:br08307]
 Antivirals
  Entry, fusion or uncoating inhibitor
   RSV F protein
    D10991  Suptavumab (USAN/INN)
Other DBs
CAS: 1629615-23-1
PubChem: 350078337
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system